SCHEMBL31422763

SCHEMBL31422763

O=C(Nc1ccccc1)Oc1c(C2CCC2)ccc2cc(C(=O)NC3C=CS(=O)(=O)C3)c(=O)[nH]c12

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CNR2 P34972 7/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ RECQL P46063 1/20 0.34
▸ JAK2 O60674 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.32
▸ SMYD3 Q9H7B4 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ HSD17B1 P14061 1/20 0.31
▸ HSD17B2 P37059 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31422832 1.00 LMNA (0.40) LMNAKMT2AMEN1CNR2SMN1; SMN2
SCHEMBL31423269 0.87 LMNA (0.42) LMNAKMT2AMEN1CNR2SMN1; SMN2
SCHEMBL31423169 0.85 CNR2 (0.45) LMNAKMT2AMEN1CNR2ALDH1A1
SCHEMBL31423295 0.82 LMNA (0.42) LMNAKMT2AMEN1CNR2SMN1; SMN2
SCHEMBL31422776 0.82 LMNA (0.42) LMNAKMT2AMEN1CNR2SMN1; SMN2
SCHEMBL31423174 0.82 LMNA (0.49) LMNAKMT2AMEN1CNR2SMN1; SMN2
SCHEMBL31423041 0.82 CNR2 (0.41) LMNAKMT2AMEN1CNR2SMN1; SMN2
SCHEMBL31422764 0.82 LMNA (0.40) LMNAKMT2AMEN1CNR2SMN1; SMN2
SCHEMBL31422934 0.81 MEN1 (0.41) LMNAKMT2AMEN1CNR2SMN1; SMN2
SCHEMBL31422769 0.81 LMNA (0.40) LMNAKMT2AMEN1CNR2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085233-A1 NOVEL DERIVATIVES OF QUINOLINONES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-04-24 — — WO disclosed
Send feedback